Abstract
Purpose:
To evaluate the efficacy of Combined subconjunctival with subscleral Ologen implantation in glaucoma filtering surgery.
Methods:
15 eyes of 15 patients underwent fornix based trabeculectomy with insertion of ologen implant both subsclerally and subconjunctivally (double ologen) without the use of Mitomycin-C/5-Flurouracil. All patients had a minimum of 12 months follow up. Pre-operative data and post-operative data at 1 week, 1 month, 3 months, 6months and thereafter every 6 months for BCVA, applanation tonometry, bleb morphology & leaks, lens status, antiglaucoma medications, perimetry & any complications were noted.
Results:
The average age of patients was 50.86±14.76yrs (range 18-68 years). The male:female ratio was 10:5. The diagnosis were varied with 3 patients having Juvenile open angle glaucoma, 4 patients with Primary open angle glaucoma, 8 patients with Primary angle closure glaucoma. The mean preoperative IOP was 40.67±7.88mmHg. The average follow up was 18.5±4.7mths, with a minimum of at least 12mths. Postoperatively, the IOP at 3mths was 11.13±2.74mmHg; 6mths was 12.11±2.14mmHg; 12mths was 13.33±2.69mmHg. All patients had IOP≤18mmHg with no additional antiglaucoma medications. The preoperative & postoperative BCVA in LogMAR was 0.25±0.21 and 0.28±0.22 (p=0.239). 2 patients had shallow anterior chamber in the initial postoperative day, which was reformed and subsequently patients did well. 1 patient had choroidal detachment and one patient required resutring of conjunctiva in initial postoperative days.
Conclusions:
Trabeculectomy with implantation of Ologen implant both subsclerally and subconjunctivally appears to offer encouraging short-term results in terms of IOP control in eyes with primary adult glaucoma.
Keywords: 462 clinical (human) or epidemiologic studies: outcomes/complications •
765 wound healing